Amicus Therapeutics



Amicus Therapeutics, Inc. is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living with devastating rare and orphan diseases.


Add photos to showcase Amicus Therapeutics’s culture


Add Amicus Therapeutics’s values

Insider experiences

Share your experience of working at Amicus Therapeutics

John Crowley
Chairman & CEO
Bradley L. Campbell
President and Chief Operating Officer
Daphne Quimi
Chief Financial Officer
David Clark
Chief People Officer
Ellen S. Rosenberg
Chief Legal Officer
Jayne C. Gershkowitz
Chief Patient Advocate
Jeffrey P. Castelli
Chief Portfolio Officer and Head of Gene Therapy
Patrik Florencio
Senior Vice President, Global Chief Compliance & Risk Officer
Julie Yu
Chief Program Officer
Jill Weimer
Chief Science Officer

Add your teams to show how people work together at Amicus Therapeutics

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.